Hypoxia signalling in cancer and approaches to enforce tumour regression

Cited by (1,002)

Items 201–300 of 1,002

  1. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer
    Marius Ilié, Nathalie M. Mazure, Véronique Hofman, Reda El Ammadi, Cécile Ortholan, Christelle Bonnetaud, Katia Havet, Nicolas Vénissac, Baharia Mograbi, Jérôme Mouroux et al. · 2010 · British Journal of Cancer
  2. Activation of β-Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis
    Liang Liu, Xiao‐Dong Zhu, Wenquan Wang, Yuan Shen, Yi Qin, Zhenggang Ren, Hui‐Chuan Sun, Zhao–You Tang · 2010 · Clinical Cancer Research
  3. Plaque angiogenesis and intraplaque hemorrhage in atherosclerosis
    Laura Parma, Fabiana Baganha, Paul H.A. Quax, Margreet R. de Vries · 2017 · European Journal of Pharmacology
  4. Differential Sensitivity of Hypoxia Inducible Factor Hydroxylation Sites to Hypoxia and Hydroxylase Inhibitors
    Ya‐Min Tian, Kar Kheng Yeoh, Myung Kyu Lee, Tuula Eriksson, Benedikt Mathias Kessler, Holger Kramer, Mariola J. Edelmann, Carsten Willam, Christopher William Pugh, Christopher John Schofield et al. · 2011 · Journal of Biological Chemistry
  5. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness
    Bin Bao, Asfar Sohail Azmi, Shadan S. Ali, Aamir Ahmad, Yiwei Li, Sanjeev Banerjee, Dejuan Kong, Fazlul H. Sarkar · 2012 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  6. The insulin receptor substrate (IRS) proteins
    Leslie M. Shaw · 2011 · Cell Cycle
  7. Butyrate and Colorectal Cancer: The Role of Butyrate Transport
    Pedro Gonçalves, Fátima Martel · 2013 · Current Drug Metabolism
  8. Mechanisms of resistance to antiangiogenesis therapy
    Faisal Azam, Shaveta Mehta, Adrian Llewellyn Harris · 2010 · European Journal of Cancer
  9. Dormancy in cancer
    Hiroko Endo, Masahiro Inoue · 2018 · Cancer Science
  10. Progress of exosomes in the diagnosis and treatment of lung cancer
    Kanghong Xu, Chengpeng Zhang, Tiantian Du, Abakundana Nsenga Ariston Gabriel, Xue Wang, Xiaomeng Li, Li Jun Sun, Nan Wang, Xinquan Jiang, Yi Zhang · 2020 · Biomedicine & Pharmacotherapy
  11. The HIF-1–Inducible Lysyl Oxidase Activates HIF-1 via the Akt Pathway in a Positive Regulation Loop and Synergizes with HIF-1 in Promoting Tumor Cell Growth
    Floriane Pez, Frédéric Dayan, Jérôme Durivault, Bastien Kaniewski, Géraldine Aimond, Gabrielle S. Le Provost, Blandine Deux, Philippe Clézardin, Pascal Sommer, Jacques Pouysségur et al. · 2011 · Cancer Research
  12. Genetic Disruption of Lactate/H+ Symporters (MCTs) and Their Subunit CD147/BASIGIN Sensitizes Glycolytic Tumor Cells to Phenformin
    Ibtissam Marchiq, Renaud LeFloch, Danièle Roux, Marie‐Pierre Simon, Jacques Pouysségur · 2014 · Cancer Research
  13. Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia
    Annamaria Rapisarda, Giovanni Melillo · 2012 · Nature Reviews Clinical Oncology
  14. Warburg and Beyond: The Power of Mitochondrial Metabolism to Collaborate or Replace Fermentative Glycolysis in Cancer
    Shamir Cassim, Milica Vučetić, Maša Ždralević, Jacques Pouysségur · 2020 · Cancers
  15. Hypoxia-inducible MicroRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma
    Ying Qiao, Linhui Liang, Weijie Guo, Ruopeng Zha, Qi Tian, Shenglin Huang, Jian Yao, Jie Ding, Meiyan Bao, Chao Ge et al. · 2010 · Hepatology
  16. Eag1 Expression Interferes with Hypoxia Homeostasis and Induces Angiogenesis in Tumors
    Bryan Downie, Araceli Sánchez, Hendrik Knötgen, Constanza Contreras‐Jurado, Marco Gymnopoulos, Claudia Weber, Walter Stühmer, Luis A. Pardo · 2008 · Journal of Biological Chemistry
  17. microRNA: Emerging therapeutic targets in acute ischemic diseases
    Pasquale Fasanaro, Simona Greco, Mircea Ivan, Maurizio Colognesi Capogrossi, Fabio Martelli · 2009 · Pharmacology & Therapeutics
  18. Hypoxia-Inducible Factor Signaling in Pheochromocytoma: Turning the Rudder in the Right Direction
    Ivana Jochmanová, Chunzhang Yang, Zhengping Zhuang, Karel Pacák · 2013 · JNCI Journal of the National Cancer Institute
  19. Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma
    Zhikui Liu, Yufeng Wang, Changwei Dou, Meng Michelle Xu, Liankang Sun, Liang Wang, Bowen Yao, Qing Li, Wei Yang, Kangsheng Tu et al. · 2018 · Theranostics
  20. Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models
    Ran Wei, Limin Mao, Ping Xu, Xinghai Zheng, Robert M. Hackman, Gerardo Guillermo Mackenzie, Yuefei Wang · 2018 · Food & Function
  21. ‘Warburg effect’ controls tumor growth, bacterial, viral infections and immunity – Genetic deconstruction and therapeutic perspectives
    Jacques Pouysségur, Ibtissam Marchiq, Scott K. Parks, Jérôme Durivault, Maša Ždralević, Milica Vučetić · 2022 · Seminars in Cancer Biology
  22. The Hypoxia-controlled FBXL14 Ubiquitin Ligase Targets SNAIL1 for Proteasome Degradation
    Rosa Viñas-Castells, Manuel Beltran-Nebot, Gabriela Valls, Irene Gómez, José Miguel García, Bàrbara Montserrat-Sentís, Josep Baulida, Félix Bonilla, Antonio Garcı́a de Herreros, Víctor M. Diaz · 2009 · Journal of Biological Chemistry
  23. Hypoxia: A key feature of COVID-19 launching activation of HIF-1 and cytokine storm
    Mozhgan Jahani, Sadat Dokaneheifard, Kamran Mansouri · 2020 · Journal of Inflammation
  24. Hypoxia and hypoxia inducible factors in tumor metabolism
    Wen Zeng, Peiyi Liu, Weimin Pan, Shree Ram Singh, Yiyong Wei · 2014 · Cancer Letters
  25. Tumor Heterogeneity: Mechanisms and Bases for a Reliable Application of Molecular Marker Design
    Salvador J. Díaz‐Cano · 2012 · International Journal of Molecular Sciences
  26. Induction of the Heat Shock Pathway during Hypoxia Requires Regulation of Heat Shock Factor by Hypoxia-inducible Factor-1
    Nathan A. Baird, Douglas W. Turnbull, Eric A. Johnson · 2006 · Journal of Biological Chemistry
  27. Negative Regulation of Hypoxic Responses via Induced Reptin Methylation
    Jason S. Lee, Yun-Ho Kim, Ik Soo Kim, Bogyou Kim, Hee June Choi, Ji Min Lee, Hijai R. Shin, Jung Hwa Kim, Ji-Young Kim, Sang‐Beom Seo et al. · 2010 · Molecular Cell
  28. AMP-Activated Protein Kinase and Autophagy
    Alfred J. Meijer, Patrice Codogno · 2007 · Autophagy
  29. Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer
    Davinder Pal Singh, Rohit Arora, Pardeep Kaur, Balbir Singh, Rahul Mannan, Saroj Arora · 2017 · Cell & Bioscience
  30. Inhibiting Hypoxia-Inducible Factor 1 for Cancer Therapy
    Giovanni Melillo · 2006 · Molecular Cancer Research
  31. Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma
    Roshan Mahabir, Mishie Ann Tanino, Aiman Elmansuri, Lei Wang, Taichi Kimura, Tamio Itoh, Yusuke Ohba, Hiroshi Nishihara, Hiroki Shirato, Masumi Tsuda et al. · 2013 · Neuro-Oncology
  32. Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin
    Zhao, Xiao, Gao, Song, Ren, He, Sun, Wei, Zhang, Huan, Sun, Jianwei, Yang, Shengyu, Hao, Jihui · 2014 · Cancer Research
  33. Molecular mechanisms of hypoxia in cancer
    Amarnath Challapalli, Laurence S. Carroll, Eric Ofori Aboagye · 2017 · Clinical and Translational Imaging
  34. Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1
    Dong Hoon Shin, Yang‐Sook Chun, Dong Soon Lee, Eric L. Huang, Jong‐Wan Park · 2008 · Blood
  35. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy
    Reshef Tal, James H. Segars · 2013 · Human Reproduction Update
  36. Towards principled design of cancer nanomedicine to accelerate clinical translation
    Souri, Mohammad, Soltani, M., Moradi Kashkooli, Farshad, Kiani Shahvandi, Mohammad, Chiani, Mohsen, Shariati, Fatemeh Sadat, Mehrabi, Mohammad Reza, Munn, Lance L. · 2022 · Materials Today Bio
  37. Therapeutic targeting of the Warburg effect in pancreatic cancer relies on an absence of p53 function
    Rajeshkumar, N.V., Dutta, Prasanta, Yabuuchi, Shinichi, de Wilde, Roeland F., Martinez, Gary V., Le, Anne, Kamphorst, Jurre J., Rabinowitz, Joshua D., Jain, Sanjay K., Hidalgo, Manuel et al. · 2015 · Cancer Research
  38. Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs – an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research
    Salvador Harguindey, José Antonio Arranz, Julian David Polo Orozco, Cyril Rauch, Stefano Fais, Rosa Angela Cardone, Stephan J. Reshkin · 2013 · Journal of Translational Medicine
  39. Diet, Autophagy, and Cancer: A Review
    Keith W. Singletary, John Milner · 2008 · Cancer Epidemiology Biomarkers & Prevention
  40. The role of histone deacetylases in prostate cancer
    Ata Abbas, Sanjay Gupta · 2008 · Epigenetics
  41. Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype
    Stéphane Garcia, Jean-Philippe Dalès, Emmanuelle Charafe‐Jauffret, Séverine Carpentier-Meunier, L Andrac, Jocelyne D. Jacquemier, Claudine Andonian, Marie‐Noëlle Lavaut, Claude Allasia, Pascal Bonnier et al. · 2007 · Human Pathology
  42. Acidic Environment Leads to ROS-Induced MAPK Signaling in Cancer Cells
    Anne Riemann, Bettina Schneider, Angelika Ihling, Martin Nowak, Christoph Sauvant, Oliver Thews, Michael Gekle · 2011 · PLoS ONE
  43. HIF-1α in Epidermis: Oxygen Sensing, Cutaneous Angiogenesis, Cancer, and Non-Cancer Disorders
    Hamid Reza Rezvani, Nsrein Ali, L. Johan Nissen, Ghida Harfouche, Hubert de Verneuil, Alain Taïeb, Frédéric Mazurier · 2011 · Journal of Investigative Dermatology
  44. Application of Chitosan-Based Nanocarriers in Tumor-Targeted Drug Delivery
    Mohammad Ali Ghaz-Jahanian, Farzin Abbaspour‐Aghdam, Navideh Anarjan, Aydin Berenjian, Hoda Jafarizadeh‐Malmiri · 2014 · Molecular Biotechnology
  45. The role of autophagy induced by tumor microenvironment in different cells and stages of cancer
    Xue Feng Yang, Dandan Yu, Fei Yan, Yingying Jing, Zhipeng Han, Kai Sun, Lei Liang, Jing Hou, Lixin Wei · 2015 · Cell & Bioscience
  46. Current Understanding on EGFR and Wnt/ -Catenin Signaling in Glioma and Their Possible Crosstalk
    Indranil Paul, S. Bhattacharya, A. Chatterjee, Mrinal K. Ghosh · 2013 · Genes & Cancer
  47. Noninvasive Detection of Target Modulation following Phosphatidylinositol 3-Kinase Inhibition Using Hyperpolarized 13C Magnetic Resonance Spectroscopy
    Christopher Scott Ward, Humsa S. Venkatesh, Myriam M. Chaumeil, Alissa Brandes, Mark Van Criekinge, Hagit Dafni, Subramaniam Sukumar, Sarah J. Nelson, Daniel B. Vigneron, John V. Kurhanewicz et al. · 2010 · Cancer Research
  48. Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction
    Paul C. McDonald, Shawn C. Chafe, Shoukat Dedhar · 2016 · Frontiers in Cell and Developmental Biology
  49. Transcription Factor YY1 Promotes Cell Proliferation by Directly Activating the Pentose Phosphate Pathway
    Shourong Wu, Huimin Wang, Yanjun Li, Yudan Xie, Can Huang, Hezhao Zhao, Makoto Miyagishi, Vivi Kasim · 2018 · Cancer Research
  50. New Perspective for an Old Antidiabetic Drug: Metformin as Anticancer Agent
    Alessandra Leone, Elena Di Gennaro, Francesca Bruzzese, Antonio Avallone, Alfredo Budillon · 2013 · Cancer treatment and research
  51. Nitric oxide, apoptosis and macrophage polarization during tumor progression
    Andreas Weigert, Bernhard Brüne · 2008 · Nitric Oxide
  52. CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia
    Xinggang Mao, Xiaoyan Xue, Liang Wang, Xiang Zhang, M. Yan, Y.-y. Tu, W. Lin, Xiaofan Jiang, He Ren, Wei Zhang et al. · 2013 · Neuro-Oncology
  53. Hypoxia Induces Genomic DNA Demethylation through the Activation of HIF-1α and Transcriptional Upregulation of MAT2A in Hepatoma Cells
    Quanyan Liu, Li Liu, Yuhong Zhao, Jin Zhang, Dongfeng Wang, Jiwei Chen, Yueming He, Jianguo Wu, Zhonglin Zhang, Zhisu Liu · 2011 · Molecular Cancer Therapeutics
  54. Review: Implications of In Vitro Research on the Effect of Radiotherapy and Chemotherapy Under Hypoxic Conditions
    An Wouters, Bea Pauwels, Filip Lardon, Jan Baptist Vermorken · 2007 · The Oncologist
  55. Nuclear factor-κB, p53, and mitochondria: regulation of cellular metabolism and the Warburg effect
    Renée Johnson, Neil D. Perkins · 2012 · Trends in Biochemical Sciences
  56. Tumor Reoxygenation and Blood Perfusion Enhanced Photodynamic Therapy using Ultrathin Graphdiyne Oxide Nanosheets
    Jiang, Wei, Zhang, Zhen, Wang, Qin, Dou, Jiaxiang, Zhao, Yangyang, Ma, Yinchu, Liu, Huarong, Xu, Hangxun, Wang, Yucai · 2019 · Nano Letters
  57. Systemic and renal lipids in kidney disease development and progression
    PATRICIA W. WAHL, Gloria Michelle Ducasa, Alessia Fornoni · 2015 · American Journal of Physiology-Renal Physiology
  58. mTORC1 Promotes Metabolic Reprogramming by the Suppression of GSK3-dependent Foxk1 Phosphorylation
    He, Long, Gomes, Ana P., Wang, Xin, Yoon, Sang Oh, Lee, Gina, Nagiec, Michal J., Cho, Sungyun, Chavez, Andre, Islam, Tasnia, Yu, Yonghao et al. · 2018 · Molecular Cell
  59. A new generation of proto-oncogenes: Cold-inducible RNA binding proteins
    Matilde Esther LLeonart · 2009 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  60. Interdependence of HIF-1α and TGF-β/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression
    Rajit K. Basu, Susan C. Hubchak, Tomoko Hayashida, Constance E. Runyan, Paul T. Schumacker, H. William Schnaper · 2011 · American Journal of Physiology-Renal Physiology
  61. Myocardial VHL-HIF Signaling Controls an Embryonic Metabolic Switch Essential for Cardiac Maturation
    Ivan Menendez-Montes, Beatriz Escobar, Beatriz Palacios, Manuel J. Gómez, José Luis Izquierdo-García, Lorena Flores, Luis Jesús Jiménez‐Borreguero, Julián Aragonés, Jesús Ruı́z-Cabello, Miguel Torres et al. · 2016 · Developmental Cell
  62. Phosphorylation of Carbonic Anhydrase IX Controls Its Ability to Mediate Extracellular Acidification in Hypoxic Tumors
    Peter Ditte, Franck Dequiedt, Eliška Švastová, Alžbeta Hulı́ková, Anna Ohradanova‐Repic, Miriam Zaťovičová, Lucia Csáderová, Juraj Kopáček, Claudiu Trandafir Supuran, Silvia Pastoreková et al. · 2011 · Cancer Research
  63. Recent Progress and Trends in X-ray-Induced Photodynamic Therapy with Low Radiation Doses
    Liangrui He, Xujiang Yu, Wanwan Li · 2022 · ACS Nano
  64. Mechanisms of Disease: angiogenesis and the management of breast cancer
    Susana N. Banerjee, Mitch Dowsett, Alan Ashworth, Lesley‐Ann Martin · 2007 · Nature Clinical Practice Oncology
  65. Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies
    Annamaria Rapisarda, Giovanni Melillo · 2009 · Drug Resistance Updates
  66. Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect
    Aalim M. Weljie, Frank Robert Jirik · 2010 · The International Journal of Biochemistry & Cell Biology
  67. Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy
    Varda Shoshan‐Barmatz, Maya Golan · 2012 · Current Medicinal Chemistry
  68. Out of Warburg effect: An effective cancer treatment targeting the tumor specific metabolism and dysregulated pH
    Laurent H. Schwartz, Thomas N. Seyfried, Khalid Omer Alfarouk, Jorgelindo da Veiga Moreira, Stefano Fais · 2017 · Seminars in Cancer Biology
  69. Common Molecular Mechanisms of Mammary Gland Development and Breast Cancer
    Katja Lundgren, Caroline Holm, Göran Landberg · 2007 · Cellular and Molecular Life Sciences
  70. An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response
    Marco A. Calzado, Laureano de la Vega, Andreas Möller, David D.L. Bowtell, Michael Lienhard Schmitz · 2008 · Nature Cell Biology
  71. Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma
    Marco Tafani, Maura Di Vito, Alessandro Frati, Laura Pellegrini, Elena De Santis, Giovanni Sette, Adriana Eramo, Patrizio Sale, Emanuela Mari, Antonio Santoro et al. · 2011 · Journal of Neuroinflammation
  72. LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)
    Sanjiv S. Agarwala, Ulrich Keilholz, Erard M. Gilles, Agop Y. Bedikian, Jane Wu, Richard Kay, Cy Aaron Stein, Loretta Marie Itri, Stefan Suciu, Alexander M.M. Eggermont · 2009 · European Journal of Cancer
  73. Expression of SDF-1α and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer
    Naoto Yoshitake, Hirokazu Fukui, Hidetsugu Yamagishi, Akira M Sekikawa, S Fujii, Shigeki Tomita, Kazuhito Ichikawa, Johji Imura, H. Hiraishi, T. Fujimori · 2008 · British Journal of Cancer
  74. Real-Time Assessment of Tissue Hypoxia In Vivo with Combined Photoacoustics and High-Frequency Ultrasound
    Marco Gerling, Ying Heng Zhao, Salvatore Nania, K. Jessica Norberg, Caroline S. Verbeke, Benjamin Englert, Raoul Kuiper, Åsa Bergström, Moustapha Hassan, Albrecht Neeße et al. · 2014 · Theranostics
  75. Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: Biological insights from a hybrid multiscale cellular automaton model
    Gibin Powathil, Kirsty E. Gordon, Lydia Hill, Mark A. J. Chaplain · 2012 · Journal of Theoretical Biology
  76. Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
    Laurence Amiot, Soldano Ferrone, Hans Grosse‐Wilde, Barbara Seliger · 2010 · Cellular and Molecular Life Sciences
  77. The NHERF1 PDZ2 Domain Regulates PKA–RhoA–p38-mediated NHE1 Activation and Invasion in Breast Tumor Cells
    Rosa Angela Cardone, Antonia Bellizzi, Giovanni Busco, Edward J. Weinman, Maria Elena Dell’Aquila, Valeria Casavola, Amalia Azzariti, Anita Mangia, Angelo Paradiso, Stephan J. Reshkin · 2007 · Molecular Biology of the Cell
  78. Metabolism addiction in pancreatic cancer
    Roy Blum, Yoel Kloog · 2014 · Cell Death and Disease
  79. Tumor–Microenvironment Interactions: Dangerous Liaisons
    Isaac P. Witz · 2008 · Advances in cancer research
  80. Hypoxia and Hypoxia Inducible Factors in Cancer Stem Cell Maintenance
    Zhizhong Li, Jeremy N. Rich · 2010 · Current topics in microbiology and immunology
  81. Targeting the Tumor Microenvironment: Focus on Angiogenesis
    Fengjuan Fan, Alexander Schimming, Dirk Jaeger, Klaus Podar · 2011 · Journal of Oncology
  82. Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy
    Sarah Crawford · 2013 · Frontiers in Pharmacology
  83. Metabolic alterations in cancer cells and therapeutic implications
    Naima Hammoudi, Kausar Begam Riaz Ahmed, Celia Garcı́a-Prieto, Peng Huang · 2011 · 癌症:英文版
  84. Silencing the MET oncogene leads to regression of experimental tumors and metastases
    Simona Corso, Cristina Migliore, Elena Ghiso, Gaetano De Rosa, Paolo Maria Comoglio, Silvia Giordano · 2007 · Oncogene
  85. Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy
    Zhe Fu, Alexandra M. Mowday, Jeff Bruce Smaill, Ian F. Hermans, Adam Vorn Patterson · 2021 · Cells
  86. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment
    Olga Frolova, Ismael J. Samudio, Juliana Maria Benito, Rodrigo Omar Jacamo, Steven Mitchell Kornblau, Ana Karković Marković, Wendy D. Schober, Hongbo Lu, Yi Hua Qiu, Daniela Buglio et al. · 2012 · Cancer Biology & Therapy
  87. Beclin 1 deficiency is associated with increased hypoxia-induced angiogenesis
    Seon‐Jin Lee, Hong-Pyo Kim, Yang Jin, Augustine M.K. Choi, Stefan W. Ryter · 2011 · Autophagy
  88. E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1
    Bart G. M. W. Weijts, Walbert J. Bakker, Peter W. A. Cornelissen, Kuo-Hsuan Liang, Frank H. Schaftenaar, Bart Westendorp, Charlotte A C M T de Wolf, Maya Paciejewska, Colinda L. G. J. Scheele, Lindsey N. Kent et al. · 2012 · The EMBO Journal
  89. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells
    Imran Babar, Jennifer R. Czochor, Allison Steinmetz, Joanne Barnes Weidhaas, Peter M. Glazer, Frank John Slack · 2011 · Cancer Biology & Therapy
  90. Modulating Hypoxia-Inducible Transcription by Disrupting the HIF-1–DNA Interface
    Nicholas George Nickols, Claire S. Jacobs, Michelle E. Farkas, Peter B. Dervan · 2007 · ACS Chemical Biology
  91. Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
    Mun Chiang Chan, James P. Holt‐Martyn, Christopher John Schofield, Peter John Ratcliffe · 2016 · Molecular Aspects of Medicine
  92. Hypoxia Modulates HLA-G Gene Expression in Tumor Cells
    Gaël Mouillot, Céline Marcou, Inès Zidi, Christine Guillard, Déborah Sangrouber, Edgardo Delfino Carosella, Philippe Moreau · 2006 · Human Immunology
  93. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-κB activity in hypoxic tumor cells
    G -Y Jang, J -H Jeon, S -Y Cho, D -M Shin, C -W Kim, Eui Man Jeong, Han-Sol Bae, T. W. Kim, S -H Lee, Yo Han Choi et al. · 2009 · Oncogene
  94. 18F-FDG Avidity of Pheochromocytomas and Paragangliomas: A New Molecular Imaging Signature?
    David Taïeb, Frederic A. Sebag, Anne Barlier, Laurent Tessonnier, Fausto F Palazzo, Isabelle Morange, Patricia Niccoli, Nicolas Fakhry, C. De Micco, Serge Cammilleri et al. · 2009 · Journal of Nuclear Medicine
  95. 3-Bromopyruvate: A New Targeted Antiglycolytic Agent and a Promise for Cancer Therapy
    Shanmugasundaram Ganapathy‐Kanniappan, M. Vali, Rani Kunjithapatham, Manon Buijs, Labiq H. Syed, Pramod Prabhakar Rao, S. Ota, B K Kwak, Romaric Loffroy, J.F. Geschwind · 2010 · Current Pharmaceutical Biotechnology
  96. Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance
    Jie Yang, Wei Li, Lihua Luo, Mengshi Jiang, Chunqi Zhu, Bing Qin, Hang Yin, Xiaoling Yuan, Xiaoyi Yin, Junlei Zhang et al. · 2018 · Biomaterials
  97. Nitric oxide and superoxide: Interference with hypoxic signaling
    Bernhard Brüne, J ZHOU · 2007 · Cardiovascular Research
  98. Metabolic reprogramming of the tumor
    Leonardo M. R. Ferreira, Aline Hébrant, J.E. Dumont · 2012 · Oncogene
  99. The acquisition of resistance to TNFα in breast cancer cells is associated with constitutive activation of autophagy as revealed by a transcriptome analysis using a custom microarray
    Moussay, Etienne, Kaoma, Tony, Baginska, Joanna, Muller, Arnaud, Van Moer, Kris, Nicot, Nathalie, Nazarov, Petr V., Vallar, Laurent, Chouaib, Salem, Berchem, Guy et al. · 2011 · Autophagy
  100. Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells
    Tri M. Bui Nguyen, Indira V. Subramanian, Ameeta Kelekar, Sundaram Ramakrishnan · 2007 · Blood